Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis

Completed

• Conditions: Chorioamnionitis

• Registration Number: NCT03576560
• Lead Sponsor: Pediatrix

Brief Summary

Retrospective Chart Review to determine the selective use of antibiotics in neonates born to mothers with suspected chorioamnionitis

Detailed Description

To determine the incidence and types of adverse outcomes in infants born to mothers with signs of chorioamnionitis when these infants are asymptomatic and are not treated with antibiotics empirically.

Study Timeline

• Study Start: 2017-06-26
• Study First Submitted: 2018-06-26
• Study First Submitted QC: 2018-06-26
• Study First Posted: 2018-07-03
• Primary Completion: 2019-03-01
• Study Completion: 2019-05-01
• Status Verified: 2019-06
• Last Update Submitted: 2019-06-20
• Last Update Posted: 2019-06-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 768

Inclusion Criteria

• Mother/baby dyads in which the mother was diagnosed with chorioamnionitis and/or had intrapartum fever (as diagnosed by obstetrician)

Exclusion Criteria

None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Infants born to mother with chorioamnionitis/intrapartum fever as assessed by chart review.	Infants born from July, 2012 to December 31, 2018.	The retrospective chart review would analyze the total number of infants born to mothers with chorioamnionitis/intrapartum fever.

Trial Locations

Locations (1)

Women's Hospital of Greensboro; 🇺🇸 Greensboro, North Carolina, United States